NCT07161180 - "Evaluation of the Pharmacokinetics of PBK_M2301 in Healthy Adults" | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 27, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

November 30, 2025

Conditions

Healthy Volunteers

Interventions

DRUG

PBK_M2301 (levodropropizine + Pelargonium sidoides extract)

A single oral tablet containing levodropropizine 60 mg and Pelargonium sidoides extract (11% ethanol dried extract, 5.5\~6.6→1) 20 mg. Administered after at least 10 hours of fasting with 150 mL of water at room temperature.

DRUG

R1_PBK_M2301 (levodropropizine)

A single oral tablet containing levodropropizine 60 mg. Administered after at least 10 hours of fasting with 150 mL of water at room temperature.

DRUG

R2_PBK_M2301 (Pelargonium sidoides extract)

A single oral tablet containing Pelargonium sidoides extract (11% ethanol dried extract, 5.5\~6.6→1) 20 mg. Administered after at least 10 hours of fasting with 150 mL of water at room temperature.

Trial Locations (1)

08799

RECRUITING

H+ Yangji Hospital, Seoul